Natural disasters, such as Hurricane Maria, may have contributed to more acute shortages than previously experienced. By Jorge Garcia, PharmD, MS, MHA, MBA, and Dina B. Dumercy, PharmD, BCOP, BCPS […] Read more
By Pedro N. Aguiar Jr., MD, MSc, andGilberto L. Lopes Jr., MD, MBA Posted: April 2018 After often-painful but effective and still incomplete economic reforms, more rational government spending, and […] Read more
Using Deep Learning Systems to Radiologically Predict Pathologic Invasiveness in Lung Adenocarcinoma
By Masahiro Yanagawa, MD, PhD, andNoriyuki Tomiyama, MD, PhD Posted: April 2018 Improvement in computer capacity, the expansion of computer networks, and the emergence of big data have resulted in […] Read more
By AnnMarie Estrada, IASLC Foundation Director Posted: February 2018 When you think of the IASLC, you think about professional development, networking, and renowned international lung cancer conferences. When you consider […] Read more
National Cancer Institute Adds Latest Clinical Trial to the ALCHEMIST Platform
By Cynthia L. Kryder, MSPosted: December 2017 Despite genomic advances in the treatment of advanced lung cancer over the past decade, few breakthroughs have emerged in the adjuvant treatment of […] Read more
Comments on the 8th Edition of the TNM Classification of Lung Cancer
Fabrice Barlesi, MD, PhD+more
By Fabrice Barlesi, MD, PhD, and Eric Vallières, MD, FRCSC An article by Cynthia Kryder and Ramón Rami-Porta in the IASLC Lung Cancer News recently highlighted the innovations of the […] Read more
World No-Tobacco Day 2017: Women Against Lung Cancer in Europe’s European Union Event on Primary Prevention
By Gian Piero Bandelli, MD, Federica Ferraresi, WALCE Advocate, and Silvia Novello, MD, PhD On the occasion of World No Tobacco Day 2017, Women Against Lung Cancer in Europe (WALCE), […] Read more
By Cynthia L. Kryder, MS, CCC-Sp Rearrangements in the anaplastic lymphoma kinase (ALK) gene occur in approximately 2% to 7% of patients with advanced non-small cell lung cancer (NSCLC).1 For […] Read more
Posted: June 2017 By Νiki Karachaliou, MD, PhD The identification of oncogenic driver alterations in non-small cell lung cancer (NSCLC), such as EGFR mutations and ALK rearrangements, each of which […] Read more
IASLC International Mentorship Program Boosts Early Careers, Fosters International Collaboration
Posted: April 2017 By Keightley Amen, BA, ELS To help ensure that high-quality thoracic oncology care is available throughout the world and well into the future, the IASLC offers an […] Read more